+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oral Proteins & Peptides Market by Product Type, Formulation, Development Stage, Application, End-User - Global Forecast to 2030- Product Image
Oral Proteins & Peptides Market by Product Type, Formulation, Development Stage, Application, End-User - Global Forecast to 2030- Product Image
Sale

Oral Proteins & Peptides Market by Product Type, Formulation, Development Stage, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968731
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Oral Proteins & Peptides Market is rapidly transforming healthcare by advancing non-invasive therapeutics, enhancing adherence, and optimizing outcomes in multiple disease areas. Senior decision-makers require precise, actionable insights to navigate this evolving space and seize emerging opportunities.

Market Snapshot: Oral Proteins & Peptides Market

The Oral Proteins & Peptides Market grew from USD 6.89 billion in 2024 to USD 7.78 billion in 2025. The sector is projected to maintain robust momentum, expanding at a 13.33% CAGR and reaching USD 14.60 billion by 2030. This growth reflects increasing demand for oral delivery platforms, supported by significant clinical advances and the expansion of chronic disease management strategies. Key drivers include patient preference for oral over injectable therapies, technological breakthroughs in peptide stabilization, and a rise in strategic partnerships across the pharmaceutical value chain.

Scope & Segmentation

  • Product Types: Insulin-based proteins, combination insulin products, long-acting and rapid-acting insulin analogues, recombinant human insulin, peptide therapeutics, calcitonin-based therapies, glucagon-like peptide-1 receptor agonists, vasopressin analogs.
  • Formulations: Capsule formulations, liquid, powder, and tablet dosage forms—all tailored for bioavailability, shelf stability, and patient convenience.
  • Development Stages: Preclinical studies, Phase I & II clinical trials, Phase III clinical trials, and post-market surveillance—enabling market participants to track development life cycles and innovation stages.
  • Applications: Diabetes management, cardiovascular diseases, hormonal disorders, cancer treatment, and other chronic or complex disease indications.
  • End-Users: Home care settings, hospitals and clinics, research laboratories, specialty clinics—each presenting specific distribution and support considerations.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (from the United Kingdom and Germany to Saudi Arabia and South Africa), Asia-Pacific (notably China, India, Japan, Australia, and more dynamic regional markets).
  • Technologies: Absorption enhancers, protective coatings, nanocarrier systems, mucoadhesive and molecular shielding advances, digital health integration, and platform innovation supporting patient monitoring and dose optimization.
  • Key Companies: Novo Nordisk, Eli Lilly, Sanofi, Ferring Pharmaceuticals, AbbVie, Amgen, Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Catalent, Entera Bio, Johnson & Johnson, Merck, Novartis, Oramed Pharmaceuticals, Pfizer, Rani Therapeutics, Tarsa Therapeutics, Teva Pharmaceutical, Zealand Pharma, among others.

Key Takeaways

  • Oral protein and peptide therapeutics are now enabling delivery of complex biomolecules through patient-friendly formats, supporting better adherence and expanded use across chronic and specialty indications.
  • Formulation innovation—involving novel excipients, nanocarriers, and mucoadhesive systems—has unlocked oral delivery for drugs traditionally limited to injection, widening the candidate pipeline and supporting broader application.
  • Digital health tools and real-time monitoring are enhancing patient engagement and enabling more adaptive trial designs, supporting both regulatory compliance and improved real-world outcomes.
  • Manufacturers are strategically diversifying their supply chains and forming global partnerships in response to evolving regulatory and market access conditions, ensuring resilience to pricing and sourcing volatility.
  • Competitive landscapes are shaped by alliances between biotech innovators, contract manufacturers, and major pharma players, all aiming to accelerate clinical development and differentiation through advanced delivery technologies.
  • Regions exhibit varied adoption dynamics: the Americas lead with strong reimbursement and regulatory support, EMEA markets present complex access environments, and Asia-Pacific stands out for rapid patient growth and innovation incentives.

Tariff Impact: Strategic Considerations for 2025 and Beyond

Recent U.S. tariff adjustments have increased input costs for oral peptide therapies, driving both supply chain reshoring and strategic reassessment of global manufacturing footprints. Companies are mitigating exposure by investing in domestic production, streamlining procurement, and forming inventory partnerships that protect against volatility. Payers and distributors now face shifting negotiations and reimbursement models, prompting the industry to continually refine contracting frameworks and launch strategies in response to policy shifts.

Methodology & Data Sources

This report synthesizes secondary research—including peer-reviewed literature, regulatory documents, and industry benchmarks—and primary interviews with formulation scientists, clinical leaders, and market access experts. Proprietary databases and advanced analytics ensure credibility in correlating formulation success with clinical outcomes, while sensitivity analysis validates the segmentation frameworks.

Why This Report Matters

  • Delivers a comprehensive view of the competitive, regulatory, and technological landscape shaping the oral proteins and peptides market.
  • Equips stakeholders with segmentation intelligence, regional insights, and actionable recommendations to inform resource allocation and market entry strategies.
  • Supports due diligence for partnerships, supply chain management, and innovation investments in a sector benefitting from dynamic growth and regulatory change.

Conclusion

With innovation, strategic supply realignment, and evolving clinical practices, the oral proteins and peptides market presents growth avenues for forward-thinking organizations. Decision-makers who leverage these insights can enhance market leadership and future-proof their strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oral Proteins & Peptides Market, by Product Type
8.1. Introduction
8.2. Insulin-Based Proteins
8.2.1. Combination Insulin Products
8.2.2. Long-Acting Insulin Analogues
8.2.3. Rapid-Acting Insulin Analogues
8.2.4. Recombinant Human Insulin
8.3. Peptide Therapeutics
8.3.1. Calcitonin-Based Therapies
8.3.2. Glucagon-Like Peptide-1 Receptor Agonists
8.3.3. Vasopressin Analogs
9. Oral Proteins & Peptides Market, by Formulation
9.1. Introduction
9.2. Capsule Formulations
9.3. Liquid Formulations
9.4. Powder Formulations
9.5. Tablet Formulations
10. Oral Proteins & Peptides Market, by Development Stage
10.1. Introduction
10.2. Phase I & II Clinical Trials
10.3. Phase III Clinical Trials
10.4. Post-Market Surveillance
10.5. Preclinical Studies
11. Oral Proteins & Peptides Market, by Application
11.1. Introduction
11.2. Cancer Treatment
11.3. Cardiovascular Diseases
11.4. Diabetes Management
11.5. Hormonal Disorders
12. Oral Proteins & Peptides Market, by End-User
12.1. Introduction
12.2. Home Care Settings
12.3. Hospitals & Clinics
12.4. Research Laboratories
12.5. Specialty Clinics
13. Americas Oral Proteins & Peptides Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Oral Proteins & Peptides Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Oral Proteins & Peptides Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Amgen Inc.
16.3.3. Amryt Pharma plc
16.3.4. Astellas Pharma Inc.
16.3.5. AstraZeneca PLC
16.3.6. Biocon Limited
16.3.7. Boehringer Ingelheim International GmbH
16.3.8. Catalent, Inc.
16.3.9. Entera Bio Ltd. by DNA Biomedical Solutions
16.3.10. F. Hoffmann-La Roche AG
16.3.11. Hunan Huateng Pharmaceutical Co., Ltd. by Tasly Capital
16.3.12. Johnson & Johnson Services, Inc.
16.3.13. Merck KGaA
16.3.14. Novartis AG
16.3.15. Novo Nordisk A/S
16.3.16. Oramed Pharmaceuticals Inc.
16.3.17. PeptiDream Inc.
16.3.18. Pfizer, Inc.
16.3.19. Protagonist Therapeutics, Inc.
16.3.20. Proxima Concepts Limited
16.3.21. Rani Therapeutics, LLC
16.3.22. Sanofi S.A.
16.3.23. Tarsa Therapeutics, Inc.
16.3.24. Teva Pharmaceutical Industries Ltd.
16.3.25. Zealand Pharma A/S
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ORAL PROTEINS & PEPTIDES MARKET MULTI-CURRENCY
FIGURE 2. ORAL PROTEINS & PEPTIDES MARKET MULTI-LANGUAGE
FIGURE 3. ORAL PROTEINS & PEPTIDES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ORAL PROTEINS & PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ORAL PROTEINS & PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ORAL PROTEINS & PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COMBINATION INSULIN PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LONG-ACTING INSULIN ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RAPID-ACTING INSULIN ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RECOMBINANT HUMAN INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN-BASED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY VASOPRESSIN ANALOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CAPSULE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POWDER FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY TABLET FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE I & II CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 56. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 57. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 59. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 100. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 107. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 109. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 120. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 121. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 123. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 169. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 170. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 171. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 172. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 177. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 179. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. FINLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 198. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 200. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. EGYPT ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 205. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 206. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 207. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. TURKEY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 219. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 220. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 221. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. NORWAY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 225. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 226. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 228. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. POLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 247. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 248. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 249. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 250. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 254. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 255. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 256. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 257. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 263. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 264. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 291. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 292. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM ORAL PROTEINS & PEPT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Oral Proteins & Peptides market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Amryt Pharma plc
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biocon Limited
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Entera Bio Ltd. by DNA Biomedical Solutions
  • F. Hoffmann-La Roche AG
  • Hunan Huateng Pharmaceutical Co., Ltd. by Tasly Capital
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • PeptiDream Inc.
  • Pfizer, Inc.
  • Protagonist Therapeutics, Inc.
  • Proxima Concepts Limited
  • Rani Therapeutics, LLC
  • Sanofi S.A.
  • Tarsa Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Zealand Pharma A/S

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.6 Billion
Compound Annual Growth Rate13.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030 - Product Image

Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030

  • Report
  • 326 Pages
  • Global
From
Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Oral Proteins and Peptides Market Size, Share, Trends, and Forecast 2025-2033 - Product Image

Oral Proteins and Peptides Market Size, Share, Trends, and Forecast 2025-2033

  • Report
  • 138 Pages
  • Global
From
Oral Proteins and Peptides Market Report 2025 - Product Image

Oral Proteins and Peptides Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Formulation Development Outsourcing - Global Strategic Business Report - Product Image

Formulation Development Outsourcing - Global Strategic Business Report

  • Report
  • 84 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.